The combined frequency of >400 of these LoF-damaging ACE mutations in the general population is quite significant—up to 5%—comparable to the frequency of AD in the population > 70 y.o., which indicates that the contribution of low ACE in the development of AD could be under appreciated. This evidence concerns the gene ACE and Alzheimer disease.